RU2019138721A3 - - Google Patents

Download PDF

Info

Publication number
RU2019138721A3
RU2019138721A3 RU2019138721A RU2019138721A RU2019138721A3 RU 2019138721 A3 RU2019138721 A3 RU 2019138721A3 RU 2019138721 A RU2019138721 A RU 2019138721A RU 2019138721 A RU2019138721 A RU 2019138721A RU 2019138721 A3 RU2019138721 A3 RU 2019138721A3
Authority
RU
Russia
Application number
RU2019138721A
Other languages
Russian (ru)
Other versions
RU2774821C2 (ru
RU2019138721A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47423191&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2019138721(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2019138721A publication Critical patent/RU2019138721A/ru
Publication of RU2019138721A3 publication Critical patent/RU2019138721A3/ru
Application granted granted Critical
Publication of RU2774821C2 publication Critical patent/RU2774821C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3515—Lipophilic moiety, e.g. cholesterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
RU2019138721A 2011-06-21 2012-06-20 КОМПОЗИЦИИ иРНК ДЛЯ СХОДНОГО С АНГИОПОЭТИНОМ 3 (ANGPTL3) БЕЛКА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ RU2774821C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161499620P 2011-06-21 2011-06-21
US61/499,620 2011-06-21
US201261638288P 2012-04-25 2012-04-25
US61/638,288 2012-04-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014101627A Division RU2711799C2 (ru) 2011-06-21 2012-06-20 КОМПОЗИЦИИ иРНК ДЛЯ СХОДНОГО С АНГИОПОЭТИНОМ 3(ANGPTL3) БЕЛКА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2022116194A Division RU2867491C2 (ru) 2011-06-21 2022-06-16 КОМПОЗИЦИИ иРНК ДЛЯ СХОДНОГО С АНГИОПОЭТИНОМ 3 (ANGPTL3) БЕЛКА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ

Publications (3)

Publication Number Publication Date
RU2019138721A RU2019138721A (ru) 2021-04-26
RU2019138721A3 true RU2019138721A3 (cg-RX-API-DMAC7.html) 2021-12-02
RU2774821C2 RU2774821C2 (ru) 2022-06-23

Family

ID=

Also Published As

Publication number Publication date
EP3656860A1 (en) 2020-05-27
AU2024266805A1 (en) 2024-12-12
US20140179768A1 (en) 2014-06-26
KR102232287B1 (ko) 2021-03-29
US10934545B2 (en) 2021-03-02
RU2014101627A (ru) 2015-07-27
KR102395085B1 (ko) 2022-05-09
SG10201913683WA (en) 2020-03-30
MX360782B (es) 2018-11-16
EP2723758B1 (en) 2018-06-20
US20220073924A1 (en) 2022-03-10
JP7641997B2 (ja) 2025-03-07
JP6110372B2 (ja) 2017-04-05
US11306314B2 (en) 2022-04-19
US9322018B2 (en) 2016-04-26
JP2019013252A (ja) 2019-01-31
CN112961855B (zh) 2024-08-09
WO2012177784A2 (en) 2012-12-27
US11834662B2 (en) 2023-12-05
AU2021201547A1 (en) 2021-04-01
JP2014524738A (ja) 2014-09-25
RU2711799C2 (ru) 2020-01-22
CN107287202B (zh) 2021-03-16
US11306315B2 (en) 2022-04-19
US11332743B2 (en) 2022-05-17
AU2022201993A1 (en) 2022-04-14
CA2839573A1 (en) 2012-12-27
CN103890000B (zh) 2017-09-01
US20210171955A1 (en) 2021-06-10
BR122019026068B8 (pt) 2022-10-18
JP7245194B2 (ja) 2023-03-23
JP2020174671A (ja) 2020-10-29
BR112013033260B1 (pt) 2022-06-21
EP2723758A4 (en) 2015-04-15
JP2026113714A (ja) 2026-07-07
US20200140866A1 (en) 2020-05-07
KR102554896B1 (ko) 2023-07-12
US11306316B2 (en) 2022-04-19
US11840692B2 (en) 2023-12-12
MX2013014364A (es) 2014-07-30
KR20210035317A (ko) 2021-03-31
KR20140044870A (ko) 2014-04-15
US12467051B2 (en) 2025-11-11
US20220073929A1 (en) 2022-03-10
SG10201800715PA (en) 2018-02-27
KR20230107908A (ko) 2023-07-18
MX2022012087A (es) 2022-11-30
JP2017148048A (ja) 2017-08-31
US11525138B2 (en) 2022-12-13
US20190316137A1 (en) 2019-10-17
CN112961855A (zh) 2021-06-15
AU2022201993B2 (en) 2024-08-29
US20160186180A1 (en) 2016-06-30
CN103890000A (zh) 2014-06-25
CN107287202A (zh) 2017-10-24
WO2012177784A3 (en) 2013-02-21
US20220073926A1 (en) 2022-03-10
US20220073928A1 (en) 2022-03-10
AU2021201547B2 (en) 2022-04-07
US20190352645A1 (en) 2019-11-21
BR112013033260A8 (pt) 2017-12-19
AU2012272970A1 (en) 2014-02-06
US20240175030A1 (en) 2024-05-30
AU2017206228A1 (en) 2017-08-10
US20170355994A1 (en) 2017-12-14
JP6430559B2 (ja) 2018-11-28
US11130953B2 (en) 2021-09-28
JP6698787B2 (ja) 2020-05-27
NZ620151A (en) 2016-04-29
US10557139B2 (en) 2020-02-11
JP2023052363A (ja) 2023-04-11
EP3656860B1 (en) 2022-04-20
ES2923573T3 (es) 2022-09-28
BR122019026068B1 (pt) 2022-09-20
MX2023000053A (es) 2023-04-10
JP2025027008A (ja) 2025-02-26
KR20220063292A (ko) 2022-05-17
US10337010B2 (en) 2019-07-02
EP3444348A1 (en) 2019-02-20
US11866709B2 (en) 2024-01-09
AU2019226296A1 (en) 2019-09-26
US20220073927A1 (en) 2022-03-10
HK1199457A1 (en) 2015-07-03
AU2012272970A8 (en) 2014-02-27
BR112013033260A2 (pt) 2016-11-22
US9771591B2 (en) 2017-09-26
EP4092120A1 (en) 2022-11-23
US20210171954A1 (en) 2021-06-10
US20220235358A1 (en) 2022-07-28
JP7852018B2 (ja) 2026-04-27
EP2723758A2 (en) 2014-04-30
CA3275668A1 (en) 2026-03-02
US20220073925A1 (en) 2022-03-10
MX345095B (es) 2017-01-17
US10550390B2 (en) 2020-02-04
RU2019138721A (ru) 2021-04-26
CN120555426A (zh) 2025-08-29

Similar Documents

Publication Publication Date Title
BR112013031251A2 (cg-RX-API-DMAC7.html)
BR112013027245A2 (cg-RX-API-DMAC7.html)
BR112013024383A2 (cg-RX-API-DMAC7.html)
BR112013026905A2 (cg-RX-API-DMAC7.html)
BR112013023185A2 (cg-RX-API-DMAC7.html)
BR112013022995A2 (cg-RX-API-DMAC7.html)
BR112013017670A2 (cg-RX-API-DMAC7.html)
BR112013027830A2 (cg-RX-API-DMAC7.html)
BR112013026744A2 (cg-RX-API-DMAC7.html)
AP3853A (cg-RX-API-DMAC7.html)
BR112013023927A2 (cg-RX-API-DMAC7.html)
BR112013027452A2 (cg-RX-API-DMAC7.html)
BR112013024365A2 (cg-RX-API-DMAC7.html)
BR112013028733A2 (cg-RX-API-DMAC7.html)
BR112013027121A2 (cg-RX-API-DMAC7.html)
AP2016009466A0 (cg-RX-API-DMAC7.html)
BR112013026790A2 (cg-RX-API-DMAC7.html)
BR112013031556A2 (cg-RX-API-DMAC7.html)
BR112013032368A2 (cg-RX-API-DMAC7.html)
BR112013018949A2 (cg-RX-API-DMAC7.html)
BR112013032377A2 (cg-RX-API-DMAC7.html)
BR112013026895A2 (cg-RX-API-DMAC7.html)
BR112013027761A2 (cg-RX-API-DMAC7.html)
BR112013025487A2 (cg-RX-API-DMAC7.html)
BR112013023266A2 (cg-RX-API-DMAC7.html)